Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals

ccinfo@umn.edu | 612-624-2620 | 1-888-226-2376

Find a Clinical Trial By Drug

Drug
(NA) Not Applicable( 1 )
131 I-METAIODOBENZYLGUANIDINE( 1 )
5-AZACYTIDINE (CC-486)( 1 )
6-MERCAPTOPURINE (6-MP, PURINE( 2 )
6-THIOGUANINE (6-TG)( 2 )
Abemaciclib( 1 )
ACTR707( 1 )
Alimta (pemetrexed disodium)( 1 )
Allogeneic Latent Membrane Pro( 1 )
ALLOPURINOL( 1 )
ALT-803( 4 )
Anastrozole (Arimidex)( 1 )
Anti-Thymoctye Globulin - Equi( 1 )
ANTI-THYMOCYTE GLOBULIN (ATGAM( 1 )
Anti-Thymocyte Globulin - Rabb( 1 )
APS001F-00( 1 )
ARSENIC TRIOXIDE (AS2O3)( 1 )
ASP2215( 1 )
ASPARAGINASE( 2 )
AZD1775( 1 )
BCNU (CARMUSTINE, BICNU)( 1 )
Bevacizumab( 1 )
BLEOMYCIN (BLENOXANE)( 1 )
Blinatumomab (AMG103)( 1 )
Brentuximab vendotin (ADCETRIS( 1 )
BUSULFAN (MYLERAN)( 5 )
Cabozantinib( 1 )
CARBOPLATIN (PARAPLATIN)( 6 )
Cediranib (Recentin)( 1 )
Cefixime (Suprax)( 1 )
Cetuximab( 1 )
CISPLATIN (PLATINOL, CDDP)( 2 )
Crenolanib( 1 )
CYCLOPHOSPHAMIDE (CYTOXAN, NEO( 22 )
CYTARABINE (ARA-C, CYTOSINE AR( 4 )
CYTOXAN (CYCLOPHOSPHAMIDE)( 2 )
Dabrafenib( 1 )
DEXAMETHASONE (DECADRON)( 4 )
DEXRAZOXANE( 1 )
DNX-2401 (Tasadenoturev)( 1 )
DOCETAXEL (TAXOTERE)( 2 )
DOXORUBICIN HYDROCHLORIDE (ADR( 5 )
DSP-7888( 1 )
Elotuzumab( 1 )
Entinostat (MS-275, SNDX-275)( 1 )
Entrectinib( 2 )
ETOPOSIDE (VP-16)( 9 )
Exemestane (Aromasin)( 2 )
FATE-NK100( 1 )
FILGRASTIM (G-CSF, NEUPOGEN)( 4 )
FLUDARABINE (FLUDARA)( 13 )
FLUOROURACIL (5FU, ADRUCIL, EF( 1 )
FOLINIC ACID( 3 )
Fulvestrant( 1 )
Ganitumab (AMG 479)( 1 )
GEMCITABINE (GEMZAR)( 3 )
GM-CSF (SARGRAMOSTINE, LEUKINE( 1 )
Halaven (Eribulin Mesylate)( 1 )
HERCEPTIN (TRASTUZUMAB)( 1 )
HYDROCORTISONE( 1 )
IDARUBICIN (IDAMYCIN)( 1 )
IFOSFAMIDE (IFEX, IFOS)( 3 )
IL-2 (INTERLEUKIN-2, ALDESLEUK( 4 )
Ipilimumab( 3 )
IRINOTECAN (CPT-11, CAMPTOSAR)( 3 )
L-ASPARAGINASE( 1 )
L-ASPARAGINASE - ERWINIA( 1 )
LETROZOLE( 1 )
LEUCOVORIN CALCIUM (CITROVORUM( 3 )
Leucovorin Calcium (LV-200)( 1 )
LIPOSOMAL DOXORUBICIN( 1 )
Lynparza (Olaparib, AZD2281)( 1 )
MEDI0457 (INO-3112)( 1 )
MELPHALAN (ALKERAN)( 5 )
METHOTREXATE( 3 )
METHYLPREDNISOLONE SODIUM SUCC( 2 )
Midostaurin (PKC412)( 1 )
MITOXANTRONE( 2 )
mRNA-2416( 1 )
MSB0010718C (Anti-PD-L1)( 1 )
MYCOPHENOLATE MOFETIL( 2 )
Naloxegol( 1 )
Nivolumab (BMS-936558)( 9 )
NK cell infusion( 2 )
NKTR-102 (etirinotecan pegol)( 1 )
NKTR-214( 1 )
NKTR-262( 1 )
Olaratumab( 1 )
OXALIPLATIN( 1 )
PACLITAXEL (TAXOL)( 4 )
Paclitaxel Protein Bound (Abra( 2 )
Palbociclib (PD-0332991)( 1 )
Pegaspargase( 2 )
PEGFILGRASTIM (NEULASTA)( 1 )
PEGYLATED-LIPOSOMAL DOXORUBICI( 1 )
Pembrolizumab (Keytruda; MK-34( 7 )
Pevonedistat( 1 )
PLACEBO( 1 )
PLX3397( 1 )
PREDNISOLONE( 2 )
PREDNISONE( 2 )
Prexasertib (LY2606368)( 1 )
Rigosertib( 1 )
RITUXIMAB (RITUXAN)( 4 )
ruxolitinib( 2 )
SEL( 1 )
Selinexor (KPT-330)( 1 )
Sirolimus( 1 )
Sitravatinib (MGCD516)( 1 )
SORAFENIB( 1 )
Tacrolimus( 1 )
Talazoparib (BMN-673)( 1 )
TAMOXIFEN (NOLVADEX)( 1 )
TEMOZOLAMIDE (TEMODAL)( 1 )
THIOTEPA( 4 )
TOPOTECAN( 1 )
Total Body irradiation (TBI)( 6 )
Trametinib (Mekinist, GSK11202( 1 )
TRETINOIN( 1 )
VINCRISTINE (ONCOVIN)( 7 )
VINORELBINE (NAVELBINE)( 1 )
VP-16 (ETOPOSIDE, VEPESID)( 1 )
VX15/2503( 1 )
Xentuzumab (BI 836845)( 1 )
Protocol No Modality Phase Summary

Title

Details